Five new medicines backed for EU approval
Five therapies have been backed for approval in the European Union, including two orphan medicines addressing rare conditions.
Read More
Tag: neratinib
US OK’s Puma’s new breast cancer therapy
Puma Biotechnology’s experimental breast cancer therapy Nerlynx has been issued a green light by the US Food and Drug Administration.
Read More
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
